Mufg Americas Holdings Corp Abb Vie Inc. Transaction History

Mufg Americas Holdings Corp

$0
Q3 2023

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	BUY	$134.21 - $153.93 $63,883 - $73,270	476 Added 1.16%	41,657 $5.59 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $63,883 - $73,270	476 Added 1.16%	41,657 $5.59 Million
Q2 2022 Dec 01, 2022	SELL	$137.62 - $174.96 $46,102 - $58,611	-335 Reduced 0.81%	41,181 $6.31 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $46,102 - $58,611	-335 Reduced 0.81%	41,181 $6.31 Million
Q1 2022 Dec 01, 2022	BUY	$131.98 - $163.75 $104,660 - $129,853	793 Added 1.95%	41,516 $6.73 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $104,660 - $129,853	793 Added 1.95%	41,516 $6.73 Million
Q4 2021 Dec 01, 2022	SELL	$107.43 - $135.93 $33,625 - $42,546	-313 Reduced 0.76%	40,723 $5.51 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $33,625 - $42,546	-313 Reduced 0.76%	40,723 $5.51 Million
Q3 2021 Dec 01, 2022	BUY	$106.4 - $120.78 $407,724 - $462,828	3,832 Added 10.3%	41,036 $4.43 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $407,724 - $462,828	3,832 Added 10.3%	41,036 $4.43 Million
Q2 2021 Dec 01, 2022	SELL	$105.21 - $117.21 $151,607 - $168,899	-1,441 Reduced 3.73%	37,204 $4.19 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $151,607 - $168,899	-1,441 Reduced 3.73%	37,204 $4.19 Million
Q1 2021 Dec 01, 2022	SELL	$102.3 - $112.62 $223,730 - $246,299	-2,187 Reduced 5.36%	38,645 $4.18 Million
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $223,730 - $246,299	-2,187 Reduced 5.36%	38,645 $4.18 Million
Q4 2020 Dec 01, 2022	SELL	$80.49 - $108.67 $31,954 - $43,141	-397 Reduced 0.96%	40,832 $4.38 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $31,954 - $43,141	-397 Reduced 0.96%	40,832 $4.38 Million
Q3 2020 Dec 01, 2022	SELL	$85.91 - $100.83 $291,406 - $342,015	-3,392 Reduced 7.6%	41,229 $3.61 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $291,406 - $342,015	-3,392 Reduced 7.6%	41,229 $3.61 Million
Q2 2020 Dec 01, 2022	BUY	$73.37 - $98.18 $217,468 - $291,005	2,964 Added 7.12%	44,621 $4.38 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $756,518 - $1.01 Million	10,311 Added 30.05%	44,621 $4.38 Million
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $8,062 - $12,223	-125 Reduced 0.36%	34,310 $2.61 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $13,055 - $16,335	-181 Reduced 0.52%	34,435 $3.05 Million
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $401,056 - $482,184	-6,368 Reduced 15.54%	34,616 $2.62 Million
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $129,100 - $165,020	-1,965 Reduced 4.58%	40,984 $2.98 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $114,244 - $134,459	-1,481 Reduced 3.33%	42,949 $3.46 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $131,566 - $162,256	1,690 Added 3.95%	44,430 $4.1 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $440,549 - $489,752	-4,955 Reduced 10.39%	42,740 $0
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $363,160 - $429,700	4,045 Added 9.27%	47,695 $0
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $58,702 - $78,607	-638 Reduced 1.44%	43,650 $4.13 Million
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $262,410 - $287,755	-2,930 Reduced 6.21%	44,288 $0
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $577,799 - $738,027	-8,272 Reduced 14.91%	47,218 $0
Q2 2017 Aug 07, 2017	BUY	N/A	55,490	55,490 $0

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$34.2 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$27.4 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.6 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

52.1M
Shares

$10.4 Billion
0.84% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.74 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Account